Skip to main content
. 2017 Jul 10;14(3):2743–2748. doi: 10.3892/ol.2017.6567

Figure 1.

Figure 1.

Expression of SPOP is downregulated in human NSCLC tissue samples. (A) Reverse transcription-quantitative polymerase chain reaction analysis revealed a significantly low level of SPOP mRNA in NSCLC. (B) Representative and (C) quantified western blot analysis, which revealed a significantly lower expression level of SPOP protein in 12 representative samples of NSCLC tumor tissues (T) compared with adjacent non-tumor tissues (N). GAPDH was used as a loading control. *P<0.05 compared with normal lung tissues. SPOP, speckle-type POZ domain protein; NSCLC, non-small cell lung cancer.